1. Home
  2. SSBI vs ATYR Comparison

SSBI vs ATYR Comparison

Compare SSBI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SSBI

Summit State Bank

N/A

Current Price

$13.67

Market Cap

86.7M

Sector

Finance

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSBI
ATYR
Founded
1982
2005
Country
United States
United States
Employees
106
58
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.7M
73.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SSBI
ATYR
Price
$13.67
$0.84
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
4.1K
948.2K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.60
$0.64
52 Week High
$14.00
$7.29

Technical Indicators

Market Signals
Indicator
SSBI
ATYR
Relative Strength Index (RSI) 57.47 49.72
Support Level $12.78 $0.82
Resistance Level $13.68 $0.86
Average True Range (ATR) 0.19 0.05
MACD 0.01 0.01
Stochastic Oscillator 87.51 65.60

Price Performance

Historical Comparison
SSBI
ATYR

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: